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INTRODUCTION 
 
 
The biochemical basis of cellular function involves the intricate interplay 
of signaling molecules, receptors, and lipid (fatty-acid) membranes. The ubiquity 
of membranes, from the outer membrane that protects a eukaryotic cell to the 
different membranes that surround each intracellular constituent, accentuates their 
importance in cellular life. Proteins, associated with biological membranes, carry 
out the majority of the biological functions of these fluid lipid bilayers and are 
responsible for regulating the flow of chemical information in and out of the cell.  
Membrane fluidity adds versatility to the cell by allowing its membrane surface 
components to easily redistribute, to readily recognize cellular signals, and to 
participate in all kinds of life-sustaining biological reactions. Because of the 
specificity in evolved biochemical recognition, mimicking these functionalities in 
artificial membrane systems for their application as biosensors, biochemical 
reactors, drug-screening devices and hybrid-cell communication systems is 
desirable [1].   
Anchoring a protein to a lipid membrane is generally achieved by 
modifying the protein of interest with a lipid molecule (i.e., lipidating) that can 
anchor into a biomimetic lipid membrane. Efforts to capture the natural elegance 
and efficiency of in vivo post-translational modifications and coordination of 
these modified proteins in artificial membrane systems have been limited by both 
the types of lipids that can be attached to the protein and by the location along the 
protein at which lipidation can be successfully performed. These limitations can 
potentially be addressed by using a recently developed “aldehyde tag” 
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technology, i.e., the site-specific integration of the non-standard amino acid 
formylglycine which bears a reactive aldehyde side chain for further chemical 
modification [2]. This aldehyde functional group potentially opens also a versatile 
avenue for synthetic protein lipidation by facilitating the site-specific covalent 
attachment of lipids with aminooxy-modified head groups. The main goal of this 
study is to develop a proof of principle demonstrating the successful site-specific 
insertion of an aldehyde side chain to an enhanced green fluorescence protein 
(EGFP) for subsequent lipidation at the aldehyde site and incorporation into a 
fluid supported lipid bilayer. An EGFP was aldehyde-tagged at the carboxyl-
terminus and covalently bonded to an aminooxy-modified phospholipid 
(specifically a phosphatidylethanolamine). The successful incorporation of the 
resulting aldehyde-tagged EGFP lipid anchor constructs into a solid-supported 
lipid bilayer was verified by fluorescence microscopy. Fluorescence recovery 
after photo-bleaching (FRAP) was used to confirm the preservation of the fluidity 
of both the EGFPs and lipids in the bilayer. 
 
BACKGROUND 
 
1.  The Biological Importance of Lipid Bilayers 
 The prevalence of lipid membranes in partitioning cellular function, from 
the homeostatic processes across the bilayers that separate intracellular organelles 
to the more complex signaling mechanisms that drive organ systems, confirms 
their importance in mediating cellular life. Cells are dynamic; they communicate, 
react, and constantly change their physical and chemical characteristics to ensure 
 proper cell function, survival, and proliferation [3]. The chemical recognition of 
both intra- and extracellular signals is one of the most important membrane
biochemical processes. In many of t
around a bound antigen in order for the subsequent steps in signal transduction to 
occur. For example, through a process called receptor
specific molecules are recognized by outer
small section of a membrane to pinch off and encase the molecules, thereby 
facilitating their transport between organelles and cells. Therefore, a large number 
of life-sustaining biochemical events are coordinated on and/or by the body
cellular membranes [3]. In addition, the lipid membrane protects and holds much 
of the cellular machinery required for cellular commu
maintenance [4].  
 Lipids are amphipathic molecules with a hydrophilic (water
group bonded to long hydrophobic (water
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 of lipids, one on top of the other, with the hydrophilic heads facing out, and the 
hydrophobic tails facing in [Figure 2]. An important consequence of this 
dynamically stable configuration is its properties as a barrier. The membrane 
houses the cell’s machinery in an
constituents by prohibiting the 
trans-membrane movement of 
most molecules and ions. 
Furthermore, the bilayer 
structure permits lipids and 
other molecules located within 
each plane of the bilayer to 
move and diffuse laterally 
across the plane of the 
membrane. This mobility 
within the membrane leaflets 
permits cellular mobility and 
the necessary dynamic rearrangement of the membrane
receptors that mediate cellular adhesion and the commun
cellular life and applications in biotechnology [3].    
 
2.  Biomimetic Membrane Interfaces and Their Important Properties
 Biological membranes serve as barriers that separate and safeguard 
neighboring cells and the intracellular organelles of a cell.  Their stability as 
barriers allows them to partition cellular space and function by limiting the 
 aqueous environment, while protecting its inner 
-associated proteins and 
ication that is integral to 
 
Figure 2: The physical organization
aqueous environments as a liposome, a micelle and in 
a section of a bilayer. Hydrophilic head
surrounding water as hydrophobic tails face each 
other inside the bilayer. Liposomes are surrounded 
by water and may also encapsulate an inner
aqueous solution [6].  
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movement of molecules across the membrane, while allowing certain processes to 
take place in different areas of the living cell. As a result, cell membranes not 
only efficiently divide up cellular life, but also must closely regulate signaling 
pathways, chemical gradients, and chemical trafficking among separated cellular 
environments [1]. Given these properties, the reasons why much of the cell’s 
important chemical activity occurs at the membrane is clear.  
From the membranes that encapsulate individual organelles to the one 
membrane protecting the entire cell, membranes in eukaryotic cells vary 
dramatically in regard to lipid composition, organization, and the cellular 
processes that take place on the surface. However regardless of a membrane’s 
chemical identity, all biological membranes must be dynamic, in the 
rearrangement of membrane constitutes in the plane of the membrane, in order to 
effectively partake in the cell’s conformational, signaling, trafficking, and 
recognition events [1]. Because of the dynamic spatial requirements for proper 
membrane function, the development of biomimetic membrane systems has 
progressed to help elucidate the biochemical and biophysical phenomena that take 
place at the membrane interface. In addition, many simplified model membrane 
systems have been created to preserve the fundamental bilayer structure and lipid 
dynamics, while enabling analysis of the roles and organization of individual 
membrane components [1]. Model membrane systems allow for the study of 
biomembrane processes at the cellular level, providing information about 
membrane properties, ligand-receptor interactions, cellular signaling events, and 
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immune responses [4, 7]. For example, supported lipid bilayers (SLBs) allow for 
the easy study of membrane surface assembly, organization, and interactions [4].  
Most important, because biomimetic lipid membranes may be tailored 
with the same lipids that make up the eukaryotic cell, they are therefore naturally 
biocompatible with living cells. Lipid-based biomembrane devices provide 
biocompatible surfaces that work in the human body and its cells. This is 
exemplified in the current developments of membrane-based technologies such as 
biosensors, biochemical reactors, drug-screening devices, clinical imaging 
nanostructures, drug/gene delivery systems and hybrid-cell communication 
systems [1,8,9].  Biosensors, such as on-chip immunoassays, which measure the 
kinetics and thermodynamics of antibody binding to membrane antigens, serve as 
an example of the powerful sensor applications of biomimetic lipid surfaces [4].  
In medical applications, liposomal anticancer drugs have proven to be a 
successful alternative treatment for tumors [10].  Hydrophilic head groups of the 
inner membrane leaflet enclose the hydrophilic drug (like attracts like) to form a 
liposome around the drug [4]. Then, the drug is delivered to the tumor, using 
antibodies or ligands that are mounted on the liposome’s outer surface, and are 
specific for antigens on the tumor cell surfaces [4]. Finally, the drug-containing 
liposome fuses with the tumor’s cell membrane and enters the cell by receptor-
mediated endocytosis to deposit the drug.  
Most, if not all, of these applications require specific proteins that 
functionalize the bilayer, allowing the membrane to take part in biochemical 
interactions.  Similarly, in the body, proteins mediate the exchange of chemical 
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signals between the cellular organelles and the cell’s external environment 
through channel proteins, receptor proteins, and antibodies. Because of the high 
level of specificity of biochemical processes, biomimetic lipid interfaces must be 
developed using proteins that can dynamically reorganize within the bilayer [3]. 
When interfacing with a live eukaryotic cell, for example, biomimetic membrane-
bound proteins should be able to follow the movement of their binding partners 
on the cell surface; e.g., the dimerization, or general oligiomerization, of protein 
receptors that is often essential to create the proper signal. There are many 
chemical identification processes that require protein receptors to aggregate and 
localize at the site of the chemical signal in order to ensure that the signal gets 
transported across the membrane [11].   
There is one more feature of a biological membrane that is difficult to 
replicate in biomimetic membrane models: the ability to phase separate (i.e., to 
alter its lipid organization), depending on its lipid composition. Phase separation 
in a bilayer, depends on the amount of the different types of lipids present, which 
may include glycophospholipids with saturated and unsaturated fatty acid chains, 
cholesterol, and sphingomyelin. During a separation event, different membrane 
components take on different configurations [Figure 3]. Coupling this membrane 
property with protein anchoring will further allow biomimetic protein-lipid 
systems to actively rearrange themselves, leading to the formation of large-scale 
dynamic structures of proteins that depend on what types of lipids the proteins are 
attached to on the biomimetic membrane [8]. For these reasons, it is imperative 
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that surface membrane proteins be anchored onto the bilayer in a fashion that 
preserves their overall function and motility. 
 
3.  Solid-Supported Lipid Bilayer Systems 
Solid-supported lipid bilayers (SLBs) are stable membrane models that 
support a variety of surface analysis techniques for studying membrane surface 
function and assembly. There are a limited variety of surfaces that can support a 
high quality membrane (i.e., one with little to no defects with high lipid mobility) 
because substrates need to be hydrophilic, smooth, and clean [11]. SLBs have 
been deposited on silicon oxide, borosilicate glass, mica, and silicon substrates 
[11]. Most important, the optical clarity of glass and silicon substrates allows for 
the easy access of the SLB’s structure with various microscopy techniques. 
Through a process called vesicle fusion, small unilamellar vesicles (SUVs) 
fuse into an enlarged vesicle before they rupture into a planar fluid bilayer on the 
substrate [Figure 4] [12]. With the help of intermolecular forces, the smaller 
vesicles fuse with each other until a critical size is reached, at which point the 
 
Figure 3: A schematic overview of phase separation. By raising and lowering the temperature 
to be above or below the transition temperature, Tm, the lipids will redistribute across the 
membrane (i.e., phase separate) according to their chemical identity. In the above image, the 
bilayer contains two types of lipids: one labeled red and the other black. 
 supported lipid bilayer and the substrate enable the membran
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solid substrate [Figure 4 and
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electrostatic forces, van der Waals 
interactions, and hydration forces 
between the lower leaflet of the 
e to remain stable 
 a 10-20Å layer of water, which is trapped 
e glass substrate [Figure 5] [11]. This layer of water 
sheets of the membrane fluid [4
us solution as the
and with ionic conditions that mirror the 
 eukaryotic cell (pH ~7.5 with ~120mM 
SLB surface. Besides the 
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-Schaefer techniques [11].  
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4.  Anchoring Proteins onto Supp
Attaching proteins to a fluid lipid membrane may be achieved by protein 
lipidation to (or acyl chain modification of) lipid anchors and by the addition of 
hydrophobic protein anchors that are made of selected amino acids [
latter method requires a hydrophobic environment for the stable production of 
proteinaceous membrane anchors, and therefore, it is difficult to carry out and 
maintain in vitro 
fluid artificial bio
anchor, a His-tag + nickel linkage, or a biotin + streptavidin binding. Each of 
these techniques has drawbacks that limit control over where and how a protein is 
positioned on the membrane, what 
what positions the attachment can take place. 
orted Lipid Bilayers 
[13]. Current lipidation methods for integrating proteins into 
membranes employ either a glycosylphosphatidylinositol (GPI) 
type of lipids the protein may attach to, and at 
 
 
Figure 5: Diagram of a solid
supported lipid bilayer. 
that the water molecules 
the bilayer from above and 
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membrane configuration
supported lipid bilayer
fluidity by resting on a 
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 Naturally occurring GPI anchors are actively used in eukaryotic cells, 
covalently attaching modified proteins to the extracellular side of the cell
membrane [14]. The GPI lipi
GPI anchors to attach only at the protein’s carboxyl terminus [Figure 6] 
the types of supported lipid 
vitro synthesis of the GPI anchors would permit the choice of acyl chain 
modification, but the chemical pro
The His-tag method involves an inserted polyhistidine sequence (6
Histidine residues
nickel (Ni) atoms present on lipid head groups at the membrane surface [Figure 
Figure 6: A diagram of a g
(GPI) anchor [15]. A GPI anchor contains a sugar region 
(the glycan core that is made up of mannose 
molecules) that binds the protein to the fatty acid or acyl 
chains. 
dation method has positioning limitations that allow 
Thus, the GPI anchor 
motif severely restricts the 
possible orientations of a 
protein incorporated on the 
membrane surface.  
Furthermore, the chemical 
identities of the two 
resulting lipid anchors are 
fixed by a post
translational modification 
mechanism in the 
eukaryotic cell’s Golgi 
apparatus, thereby limiting 
bilayer compositions that may be constr
duction of GPI is complicated [16
) at the protein’s C or N terminus, which is used to bind to 
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7]. The His-tag procedure involves a carboxyl or amino terminus bound 
polyhistidine chain that binds nickel atoms on the surface of a membrane [17]. 
Currently, only one phospholipid with a nickelated head group is commercially 
available, once again limiting the variety of lipid membrane compositions. The 
histidine + nickel interaction is also reversible and thus the amount of bound 
protein is highly sensitive to changes in pH, temperature, and time [17]. Finally, 
histidine + nickel binding is ill-defined, due to the His-tags possibly interacting 
with up to two nickel head groups and the reversible nature of this His + Ni 
interaction on the membrane surface [Figure 7].  
The biotin-streptavidin method utilizes proteins and lipids that are 
biotinylated to bind with streptavidin, a molecule that acts as a “glue” that links 
up to four biotinylated constructs [Figure 8]. However, biotinylation of particular 
amino acid side-groups may occur at multiple regions along the protein, resulting 
in a non-site specific binding with streptavidin and consequently, non-specific 
lipid attachment [18]. Furthermore, streptavidin at elevated surface concentrations 
 
Figure 7: Histidine Tag + Nickel Method: Green fluorescence proteins (GFP) were modified 
with a polyhistidine tag (containing 10 His residues) at the carboxyl or amino terminus.  His- 
tagged GFPs may bind up to two nickel atoms located on the membrane surface. Binding is 
reversible as indicated by the arrows. In the figure, lipids with nickelated head groups are 
labeled in orange [17]. 
 forms large-scale aggregates that impede the lateral motion of the lipid
proteins and prohibits the dep
biotin-streptavidin binding is difficult to predict, measure, and control.  Also, the 
commercial availability of biotinylated lipid anchors is limited.  
In summary, both the His + nickel
have been proved to successfully attach prot
However, in addition to the lim
of commercially available 
(i.e., the use of only the C and N terminus in His tag modification and the 
biotinylation of proteins)
consistency in protein attachment
the specificity of modified lipids for binding. These constraints prohibit the 
Figure 8: Biotin + streptavidin m
down T shaped anchor) 
diagram, streptavidin is attached to the membrane via linkages with biotinylated lipids on the 
surface.  Currently, the variety of biotinylated lipids that are commercially available is 
osition of large amounts of protein 
 
 and biotin + streptavidin approaches 
eins onto the membrane surface.
itations of, and the problems regarding, 
lipid anchors and the possible sites of protein lipidation 
, both methods are faced with problems of dynamic 
, competitive binding for single substrates
ethod: Proteins (balloon-shaped) containing a biotin (upside
bind with streptavidin found on the membrane surface.  As seen in the 
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exploitation of all the dynamic physicochemical properties of biomimetic 
membranes. Thus, there is a need to develop a new method that allows the 
freedom to choose from a large variety of lipid anchors and to attach them at 
virtually any location along a protein. 
 
5.  The Aldehyde Tag 
To meet this need and to overcome the limitations of current 
methodologies described above, the aldehyde tag offers a new approach to protein 
attachment that permits proteins to bind at well-defined positions with one of 
many different lipid anchor motifs. It was recently found that the site-specific 
insertion of a six-amino-acid consensus sequence (LCTPSR) into a protein’s 
amino acid chain is sufficient to target the cysteine within the hexapeptide for a 
post-translational modification by a formylglycine-generating enzyme (FGE) 
[19]. This consensus sequence, also known as the “sulfatase sequence,” along 
with FGEs, occurs naturally in eukaryotic organisms and plays a vital role in 
activating the catalytic function of sulfatases, which are enzymes that hydrolyze 
sulfate esters in the cell [20].  
While there are a variety of protein modifications, few offer the site-
specificity that is guaranteed by this consensus motif. In addition, the consensus 
sequence’s relatively small size minimizes the structural effects that would 
destabilize the protein’s structure. As seen in Figure 8, the FGE recognizes and 
acts specifically on this consensus motif and oxidizes the cysteine into a 
formylglycine, which provides a reactive aldehyde group for chemoselective 
reactions with aldehyde-specific reagents that include: aminooxy- (-ONH2) and 
 hydrazide-modified molecules [20
with these reagents to produce very stable linkages. Of great benefit is the fact 
that the consensus sequence may be inse
chain, allowing for 
accuracy, such as the covalent attachment of aminooxy
aldehyde tag [Figure 9]. As a result, the aldehyde tag provides th
and precise chemical control that is necessary to produce post
Figure 9: A diagram of the aldehyde tagging procedure. The conversion of the cysteine (C) to 
a formylglycine (FGly)
coupling to an aminooxy
Figure 8: The consensus sequence L
chain. A FGE will read only this consensus 
formylglycine, thus site
]. The aldehyde side chain binds covalently 
rted into any site along a polypeptide 
site-specific protein modification with high chemical 
-modified lipids to the 
 generates a reactive aldehyde side chain for subsequent chemical 
-modified partner (e.g., the chemical label). 
CTPSR is inserted anywhere along a protein’s amino acid 
sequence and translate the 
-specifically introducing a reactive aldehyde side chain.
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modifications on any type of protein and anywhere along its peptide chain. 
6.  The Enhanced Green Fluorescence Protein (EGFP) 
A naturally occurring protein that is found in a variety of aquatic life, 
Green Fluorescent Protein (GFP), emits a green light when excited by blue light 
and has become a well-established fluorescence marker in biological cell studies 
[21]. The discovery of GFP and its derivatives such as the more photo-stable 
Enhanced Green Fluorescent Protein (EGFP) has revolutionized molecular 
imaging with its easy application and diverse uses [21]. A potent advantage of this 
protein is the ability of the EGFP gene to be easily integrated into virtually any 
part of a protein’s DNA sequence and to be translated into a functional 
fluorophore, an excitable light-emitting structure, within its final protein structure.  
EGFP allows for the quantitative measurement of successful protein-lipid 
anchor integration. Since EGFP detection is straightforward using fluorescence 
microscopy, it is the perfect protein for testing the aldehyde tag-based lipidation 
of proteins. By measuring the green fluorescence, a quantitative measurement of 
our GFP-lipid anchor’s abundance across the supported lipid membrane can be 
achieved. 
  
7.  Fluorescence Microscopy 
 Fluorophores are essential to fluorescence microscopy and have been 
widely used in microbiology to tag and identify, with high accuracy, cells and 
their intracellular constituents. By using multiple fluorophores of different colors, 
various structures of the cell may be simultaneously imaged [22]. Fluorophores 
are molecules that emit light at defined wavelengths after they have been excited 
 with excitation light at
of synthetic and naturally occurring fluorophores available, each with their 
specific chemical target and tagging procedure
 A fluorescent microscope simultaneously irradiates excitation
collects the photons emitted by the fluorophores. This is done with the help of 
special filters that can separate the excitation and emission wavelengths of the 
fluorophores and project the emitted light onto the eyes or detector [Figure 10a].
First, photons at different wavelengths pass through an excitation filter, which 
picks out the desired wavelengths of 
selected excitation photons reflect off the surface of a dichromatic (also called a 
dichroic) mirror and travel to the specimen [Figure 10b and 11]. The excited 
fluorophores on the specimen will emit light throug
the dichroic mirror, and pass an emission filter (at the top of a filter cube) that 
only allows the emission photons to pass through and project an image of only the
fluorophores on the specimen [Figure 11] [22
(a) 
Figure 10: (a) Separation of excitation and emission light with special band filters. Notice 
photons hit the specimen and radiate
separate only a portion 
excitation filter, the 
 shorter wavelengths [22]. Currently, there is a wide variety 
 [22].   
light to excite the fluorophores. Next, the 
h an objective lens, then hit 
].  
(b) 
 spherically in all directions.  The filters collect and 
of these spherical light waves [23]. (b) Filter cube containing
fluorescence emission filter, and the dichromatic mirror [22
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8.   Fluorescence Recovery After Photo
Photo-bleaching 
fluorophores when they react with oxygen right before they emit light.  
Fluorescence recovery after photo
examine the diffusion of tagged biologic
process a region of the specimen is exposed to excitation light, which 
subsequently permanently bleaches (i.e. deactivates) the fluorophores.  Bleached 
fluorophores have their chemical structure
may no longer undergo the conformational changes that are necessary for their 
fluorescence activity. By observing the rates and patterns in fluorescence recovery 
in the bleached region over a period of time, the motion of the tagged
may be determined [22
                                  
Figure 11:  
A schematic overview
fluorescence microscope [24
Excitation photons are emitted 
from a mercury or xenon arc 
lamp to excite fluorophores on 
the sample. A dichroic mirror or 
beam splitter separates the 
excitation photons from the 
fluorophores’ emission photons 
allowing the detector to collect 
only the fluorophores emitted 
photons. An objective lens is 
used to magnify the specimen.
-Bleaching (FRAP)  
results in the irreversible break down of excited 
-bleaching (FRAP) exploits this phenomenon to 
al molecules on the specimen [22
 permanently disrupted, so that th
].  
 of a 
]. 
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MATERIALS AND METHODS 
 
1. Preparation of EGFPs with the Aldehyde Tag 
The aldehyde tag’s consensus sequence was fused to the carboxyl 
terminus of an enhanced green fluorescence protein (EGFP). All of the EGFPs 
were expressed in and extracted from an E. Coli system. In addition, to improve 
the yield of aldehyde production after EGFP translation, the consensus sequence-
EGFP fusion construct was co-expressed with the DNA sequence for a 
formylglycine-generating enzyme (FGE). FGEs specifically target the six-amino-
acid sequence to enzymatically convert the cysteine in the consensus sequence 
into a formylglycine (FGly), leading to the site-specific introduction of an 
aldehyde side chain for further chemical modification [Figure 12]. Next, the 
EGFP’s aldehyde group was reacted with commercially available phospholipid 
anchor motifs that were previously modified to bear an aminooxy reactive head 
group [For details see Appendix A].  
 
2. Aminooxy-Modification of Commercially Available Phospholipids 
Commercially available phosphatidylethanolamine (PE) phospholipids 
were aminooxy-modified to bear the (-ONH2) required to covalently react with 
the modified-EGFP’s aldehyde side chain [Figure 12 and Appendix A]. PE 
phospholipids with different acyl chains (or fatty acid chains) are available at 
Avanti Polar Lipids. The coupling of the aminooxy- group to the lipid required an 
initial reaction with a Boc-protected aminooxy-reagent, followed by boc-
deprotection to form the aminooxy-modified lipid product.  
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Overview of Aldehyde-Tagged EGFP + Aminooxy-Lipid Anchor Preparation 
(a) 
 
(b) 
 
Figure 12: 
A schematic of the aldehyde-tagging and 
lipidation process: 
 
(a) The consensus sequence (LCTPXR) was 
inserted at the EGFP’s C-terminus. Co-
expression with FGE on the same plasmid yields 
the site-specific introduction of the aldehyde 
side chain for reaction with aldehyde-specific 
binding partners (e.g., aminooxy-modified 
lipids). 
 
(b) Chemical reaction between an aldehyde 
tagged-EGFP and aminooxy- (ONH2)-lipid 
(phosphatidylserine) forms a stable covalently 
bonded protein-lipid anchor. Different 
phosphatidylethanolamine (PE) phospholipids 
of varying structure and acyl-chain (tail) 
compositions may be lipidated on an aldehyde-
tagged protein. 
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Boc groups are often used in chemical reactions to protect amine groups from 
reacting until they are needed. Therefore, first, Boc -2- (aminooxy) acetic acid 
was added to a 3-neck flask. The flask was evacuated and filled with argon. Next, 
dry methylenechoride (CH2Cl2) and carbonyldiamidazole (CDI) were added to the 
flask. The solution was left to stir for 30 minutes to allow the activation of the 
carboxylic acid group. Next, the PE phospholipid was added to the reaction and 
allowed to stir overnight at room temperature, ~25°C to facilitate coupling. 
Afterwards, the reaction intermediates were washed with 1M hydrochloric acid 
(HCl) and brine (salt water). The organic layer was then dried over magnesium 
sulfate (MgSO4), and filtered, and the remaining solvent was evaporated to yield 
the boc-protected lipid [Appendix A]. Next, the modified lipids were dissolved in 
1:1 CH2Cl2: TFA (Trifluoroacetic acid) and allowed to stir for 2 hours. To remove 
the boc- group, TFA and CH2Cl2 were evaporated to generate the deprotected 
aminooxy-modified lipid for the subsequent reaction with an aldehyde-tagged 
EGFP.  Due to the presence of residual TFA at the end of the reaction, 4M HCl in 
dioxane will be substituted in future coupling reactions. 
 
3. Preparation of Small Unilamellar Vesicles (SUVs) for Supported Lipid 
Bilayer (SLB) Formation 
Small unilamellar vesicles (SUVs) consisting of two molar percent Marina 
Blue® 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (a lipid with a 
blue fluorophore attached to its head group) and 98 molar percent 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC) were preformed. Marina Blue® DHPE was 
purchased from Invitrogen, Carlsbad, CA. All other lipids were obtained from 
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Avanti Polar Lipids, Alabaster, AL. A 50mL round-bottom flask was first washed 
with piranha etch (a mixture of sulfuric acid and hydrochloric acid). The flask was 
rinsed with distilled H2O and dried in an oven before use.  Next, the determined 
volumes of lipids were pipetted into a cleaned 50mL round-bottom flask 
containing 1mL of chloroform. The contents were mixed manually before the 
chloroform was evaporated with a Büchi RE-111 Rotovapor. Next, 1mL of 
distilled H2O was added to the dried lipid mix to initiate the formation of vesicles 
of varying sizes. These vesicles were allowed to hydrate overnight. The vesicles 
were extruded using a LIPEXTM extruder (from Northern Lipids Inc., Burnaby, 
BC, Canada) to produce a solution of uniformly sized 100nm or smaller vesicles. 
These small vesicles are normally stable for a week and are necessary for vesicle 
fusion to occur during bilayer deposition. Once extruded, the resulting solution of 
vesicles (~1mL of solution of ~100nm lipid vesicles in H2O) was ready for 
deposition on glass coverslips (solid substrate). Fisherbrand 25CIR-1 25mm 
round glass coverslips were purchased from Fisher Scientific, Pittsburg, PA.  
4. Deposition of SLBs 
To construct a high-quality fluid bilayer, the glass substrate must be 
vigorously cleaned to minimize the number of defects in the bilayer. Glass 
coverslips were first sonicated and degassed in a beaker of isopropanol, rinsed in 
double ionized water, and dried under nitrogen gas. Next, the glass was treated 
with piranha etch, a solution of three parts 98% sulfuric acid with one part 33% 
hydrochloric acid for a 10-minute interval. Piranha acid dissolves organic 
molecules and leaves the glass negatively charged. Finally, the coverslips were 
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thoroughly rinsed with double distilled H2O and dried under nitrogen right before 
bilayer deposition. SUVs were allowed to fuse together and form a bilayer on the 
glass surface. The deposition procedure took two forms (both via vesicle fusion): 
Method 1  
A 3:1 volume mixture of buffer solution (containing 150mM NaCl and 
20mM Tris salt at pH ~7.4) to 100nm lipid-vesicle solution was prepared. SLBs 
were kept in salt buffer at approximately pH 7.4, to mimic the in vivo conditions 
of a eukaryotic cell. All standard salts and chemicals were purchased from Sigma-
Aldrich, USA. Forty microliters of this lipid mixture was pipetted onto a plastic 
petri dish. Next, a cleaned glass coverslip was placed over the droplet of vesicles 
to expedite the vesicle fusion process and initiate bilayer formation. The droplet 
of vesicles was smeared onto the glass substrate, resulting in the deposition of two 
layers of lipids across the coverslip.  As shown in Figure 5, to preserve the bilayer 
structure, a layer of water lies between one side of the bilayer and the substrate, 
while another layer of water is located in between the other side of the bilayer and 
the petri dish. The dish is next submerged in the same ~7.4 pH salt buffer 
solution, where the coverslip holding the SLB is mounted on a watertight 
coverslip holder that allows easy access with an inverted-epifluorescence 
microscope.  
Method 2   
In this method, a coverslip is first mounted on the microscope coverslip 
holder. Next, a 30-40µL drop of the desired lipid vesicles is placed on a clean 
coverslip and allowed to incubate for 10-15 minutes. Then, the coverslip is 
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submerged with buffer solution at ~7.4 pH.  A SLB should form at the spot where 
the drop was initially place.  
 
5. Incubation of Aldehyde-Tagged EGFP Lipid Anchors on a SLB 
Aldehyde-tagged EGFP lipid anchors were incorporated onto a SLB with 
three techniques.  The first technique involved passive integration, where 100µL 
to 200µL of EGFP-lipids were added directly onto a previously formed SLB 
composed of 2 mol percent MB DHPE and 98 mol percent DOPC.  The EGFP-
lipid anchors were allowed to incubate and passively integrate into the SLB, for 
12 to 24 hours at a time.   
The second approach involved the use of detergents to help keep a larger 
quantity of aldehyde-tagged EGFP lipid anchors in solution (i.e., water soluble 
and away from the large aggregates). Detergents, like lipids, are amphipathic 
molecules that contain a single hydrophobic acyl chain. They form micelles 
around molecules and are used to gather the EGFP-lipid anchors, thereby driving 
the formation of EGFP-lipid containing micelles while reducing the production of 
the larger lipid aggregates. Micelles are similar to liposomes where amphipathic 
molecules containing only one hydrophobic chain (as oppose to the two fatty acid 
chains found in lipids), aggregate in aqueous solution with their hydrophobic tails 
protected at the micelle center [Figure 2]. The EGFP-containing micelles were 
directly pipetted onto a SLB and allowed to incubate for 12 to 24 hours.   
The third method required the deposition of proteoliposomes that resulted 
from reacting the aldehyde-tagged EGFP onto SUVs that contained the 
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aminooxy-lipid. A vesicle solution containing 1 molar percent of the aminooxy-
modified lipids, along with 1 mol percent MB-DHPE, and 98 mol percent DOPC, 
was prepared in the same fashion as described above. These aminooxy-containing 
liposomes were extruded to form SUVs and allowed to react with the aldehyde-
tagged EGFP.  On average, three aldehyde-tagged EGFPs were added for one 
aminooxy-modified lipid on the SUVs. The aldehyde side chains of the EGFPs 
covalently bonded to the free aminooxy- groups on the preformed vesicles, 
resulting in a solution of vesicles that contain the modified or tagged EGFP. 
These vesicles were next separated by size exclusion chromatography to separate 
the successfully coupled EGFP-proteoliposomes from the unbound or unmodified 
EGFPs (i.e., non-aldehyde tagged) in solution. To improve the yield of EGFP-
proteoliposomes, SUVs containing 3 molar percent of the aminooxy-modified 
lipids, along with 2 mol percent MB-DHPE, and 95 mol percent DOPC were 
made to react with, on average, thirty aldehyde-tagged EGFPs per aminooxy-
modified lipid. Given the presence of non aldehyde-tagged EGFP (that has no 
binding partners) in solution, the higher EGFP concentration was used to ensure 
ample amounts of aldehyde-tagged EGFPs were coupled to the liposomes.  
 
6. Size Exclusion Column Chromatography 
A column was prepared with Sephacryl™ beads made from a polymer of 
allyl dextran and N, N’-methylene bisacrylamide. A 133mm glass column was set 
up to contain 1500µL of Sephacryl™ CL2B-300 beads in suspension. Beads had 
pores of various sizes. Large molecules can easily pass around the beads and elute 
out of the column, while smaller molecules must travel a longer path, through the 
 bead’s pores, before coming out of the column. A sample of the EGFP
proteoliposomes was run through the column. Sephacryl™ beads were chosen 
with a 50µm pore size, which hindered the journey of the 
unmodified EGFPs as significantly larger EGFP
During the separation, fractions were collected after each drop, and at the end 
each fraction was profiled for its contents by probing each fraction for EGFP
fluorescence with laser light. 
EGFP-proteoliposomes and free EGFPs started and finished traveling through the 
column [Figure 13
deposited via vesicle fusion and imaged with fluorescence microscopy.
Figure 13: An intensity plot of the fractions obtained from a size exclusion column. Each 
fraction was exposed to excitation photons and probed for the presence of EGFP and MB 
DHPE. Fractions containing the successfully coupled aldehyde
displayed both blue 
 
smaller unbound or 
-liposomes were quickly filtered. 
A clean separation should clearly indicate where the 
]. Fractions verified to contain EGFP-proteoliposomes were 
-tagged EGFP liposomes 
and green fluorescence. 
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 7. FRAP Analysis of 
The quantitative determination of integration efficiencies as a function of 
physical parameters (mostly the solution concentration of the EGFP
construct) calls for fluorescence microscopy and 
photo-bleaching (FRAP).
either a Nikon 60X water or
were taken with an epifluorescence microscope and
Elements Advance Research
SLBs, FRAP is used to study the changes in intensity by exploiting the self
rearranging ability of the lipid
macromolecules in the bila
(Tucson, AZ) Cascade II 1024 EMCCD
used to take time lapse photographs of the FRAP recovery. A
was used to deactivate (“bleach”)
Supported Lipid Bilayers 
fluorescence recovery after 
 Supported lipid bilayers (SLBs) were imaged with
 oil immersion objectives. FRAP analysis images 
 investigated using
 imaging software provided by Nikon, Japan. In 
 membranes to provide evidence that the 
yer are functional and mobile. A 
 camera connected to the microscope was 
 strong pulse of light 
 fluorophores (i.e., the MB DHPE and 
Figure 14: A FRAP sequence 
of a bilayer containing His
tagged EGFP. The bleached 
(black) region gradually 
recovers its intensity as mobile 
lipids carrying functional EGFP 
move into the space. The 
amount of time it takes for 
strong recovery depends on the 
protein-lipid anchor and its 
membrane environment.
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lipid anchors) on a SLB.  The laser light was kept on at specific wavelengths that 
excited the fluorophores. With the laser turned off, active fluorophores attached to 
neighboring lipids diffused into the region and effectively brightening the space 
with a slightly darker shade of the original fluorescence color [Figure 14] [25]. 
Therefore, FRAP directly measured the percentage of fluorescence recovery and 
the speed and time it took for the fluorophores to re-occupy the darkened region 
[25]. 
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RESULTS AND DISCUSSION 
 
1. Successful Aminooxy-Modification of Phospholipids 
Nuclear magnetic resonance (NMR) was used to study the magnetic 
resonance within the aminooxy-modified phospholipids in order to verify its 
chemical structure. A Bruker 300MHz NMR was used to obtain 1H NMR spectra 
(CDCL3) to verify the successful aminooxy-modification of lipids. The initial 
spectrum in appendix B showed the initial reactants as outlined in the materials 
and methods section. On the second NMR spectrum, the presence of methyl 
(CH3) protons on the boc-protecting group at 1.6ppm confirmed product 
formation [Appendix C]. On the last spectrum, the aminooxy-modified lipid 
product is clearly deprotected, as indicated by the loss of the signal at 1.6ppm. 
The rest of the spectra in appendix D were consistent with the proposed structure 
identified in the reaction scheme [Appendix A]. 
 
2. Successful Attachment of EGFP to Aminooxy- Lipid 
In the production of the first batch of aldehyde-tagged EGFP lipid anchors 
a ~10:1 volume ratio of aminooxy-lipids to aldehyde-tagged EGFPs was reacted 
with the aldehyde-tagged EGFP to ensure the limited amounts of EGFP would all 
be conjugated to an aminooxy- lipid. However, the excess lipids that did not get 
conjugated (to the EGFP) formed large lipid structures, as verified by 
fluorescence microscopy [Figure 15]. As a result, these proteins were unable to 
integrate into the membrane. However, aggregation of the usually very water-
soluble EGFP is a clear indication that the protein lipidation reaction per se was 
 successful. EGFP is not a hydrophobic protein and normally wo
to interact and form aggregates with. 
“clumps” verified the succ
aminooxy-modified lipids. The integration of individual EGFP
would have produced a uniform field of
EGFP-lipid molecules would distribute evenly in the membrane.
 
3. Fluorescence Analysis of SLB fro
The results
were obtained by examining the fluidity of the protein and the lipid environment. 
To that end, membrane integrity, as well as 
investigated using fluorescence recovery after photo
aldehyde-tagged EGFP reacted with the aminooxy
unilamellar vesicles (SUVs), a bilayer
The final proteoliposo
uld not seek lipids 
Therefore, the formation of these lipid 
essful coupling of the aldehyde-tagged EGFPs to the 
 green fluorescence, because mobile
 
m Proteoliposomes Deposition
 of the protein integration to a supported lipid bilayer (SLB) 
protein and lipid motility,
-bleaching (FRAP). After the 
-lipid containing small 
 was made from these proteoliposomes.  
mes contained about 1 mol percent MB DHPE, 98 mol 
 
Figure 15: The initial reaction of 
aldehyde-tagged EGFP with an 
excess amount of aminooxy
resulted in large amounts of 
“clumping,” where uncoupled 
aminooxy- lipids would for
lipid structures around the modified 
EGFP-lipid anchor constructs. 
Aggregation supported the 
successful reaction of the aldehyde
tagged EGFP to the aminooxy
lipid, since EGFP is not 
hydrophobic in nature and would 
therefore not collect around lip
As a result, the aldehyde
EGFPs must have successfully 
reacted with the aminooxy
and acquired some of the lipids’ 
hydrophobic nature.  
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 percent DOPC, and 1 mol percent
aldehyde-tagged EGFP bound to some fraction of them
DHPE was used to check
with EGFP’s green fluorescence. 
field of blue before and after GFP
displayed an intact bilayer, with few visible defects
16]. In figure 16, FRAP analysis images were taken within 5 to 10 seconds apart.
Inspection on the green channel showed noticeable recovery over an extended 
period of time (~2
presence of unbound and unmodified EGFP in solution.  Free EGFP was found to 
have likely bonded to
lateral motion of its neighboring lipids
lipids carrying functional EGFP to travel into the bleached zone. 
dark silhouette that remained
to permanently b
essentially occupied
EGFP were trying to enter
Figure 16: A FRAP time sequence of the recovery in intensi
recovery indicated an intact bilayer with mobile MB DHPE lipids.
 of aminooxy-modified lipid anchors
. The blue fluorescent MB
 the integrity of the bilayer without having to compete 
A perfect and intact bilayer displays a uniform 
 integration. FRAP analysis on the blue channel 
, that recovered well [Figure 
 to 5 hours) [Figure 17].  This slow recovery may be due to the 
 the glass substrate and remained immobile
 and thereby increasing the time it
 in the last FRAP image in Figure 17, was likely due 
ound EGFP on the glass, that had been bleached and then 
 the space where mobile lipids carrying 
. A comparison of the normalized intensity profiles of 
ty on the blue channel. Smooth 
 
31
 with 
-
 
, hindering the 
 takes for 
Furthermore, the 
aldehyde-tagged 
 
 the first and last image in the EGFP FRAP sequence indicated a
increase in the intensity of the bleached region from the first 
[Figure 15]. The obvious recovery in
mobile EGFP-lipids and the overall successfu
tagged EGFP aminooxy
 
4. Size Exclusion Purification of Proteoliposomes
The noticeable presence of unbound or unmodified (i.e., non
tagged) EGFP influenced the decision to add a purification step after the 
aldehyde-tagged EGFPs were reacted with the aminooxy
Separation of the EGFP
Figure 17: A FRAP sequence of aldehyde tagged EGFP + Aminooxy
on a SLB.  The intensity plot tracks the increasing change in intensity from the first time 
capture to the last frame (over a period of 5 hours) as mobile EGFP
the bleached region.
 
frame to the last 
 green intensity demonstrated the presence of 
l incorporation of the aldehyde
- lipid anchors into the SLB. 
 
-containing liposomes.  
-proteoliposomes was successful and produced a good 
-modified Lipid anchors 
-carrying lipids diffuse into 
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range of fractions that contained proteoliposomes. From Figure 13, the aldehyde-
tagged EGFP proteoliposomes were likely found in fractions 5 through 11 where 
intensity measurements revealed sufficient amounts of blue and green signal. 
Fractions 12 through 19 displayed only high amounts of green signal giving 
evidence that only unbound aldehyde-tagged or unmodified EGFPs were present 
in these fractions [Figure 13]. However, deposition of the proteoliposomes in 
fractions 5 through 11 produced SLBs with too little green fluorescence for a 
FRAP analysis. For the next reaction, a higher concentration of aminooxy-lipids 
will be added to the initial vesicle production, in addition to adding more 
aldehyde-tagged EGFP to the reaction.   
 
5. A Comparison: The Aldehyde Tag Modification vs. Current Protein 
Attachment Strategies 
In the development of biomimetic lipid surfaces, the aldehyde tag method 
offers unprecedented freedom to site-specifically modify proteins at any location 
along its peptide structure, thereby controlling the site where the protein will 
couple with a lipid anchor. As mentioned above, current protein attachment 
strategies such as the addition of a GPI lipid anchor may be added only at a 
protein’s C terminus and the His-tag may be applied only at both the C and N 
terminus. As a result, these two techniques only allow a lipid anchor to bind at 
one or two sites on the protein, respectively. In the biotin-streptavidin method, 
biotinylation is non-site specific resulting in the binding of biotin on various 
places on a protein. Therefore, the biotin-streptavidin method remains difficult to 
predict and control how the modified protein will attach on the lipid bilayer.  
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The His-tag and biotin-streptavidin methods are also hampered by the lack 
of diverse, and commercially available, lipid anchor motifs. In the aldehyde tag 
method, the aminooxy-modification may be performed on any commercially 
available phosphatidylethanolamine (PE) to generate diverse lipid anchors. PE 
phospholipids with varying acyl chains are commercially available from many 
vendors such as Avanti Polar Lipids (Alabaster, AL). Therefore, an aldehyde-
tagged protein may bind to a variety of different phospholipid anchors with 
different fatty acid chains.  This versatility promotes the development of diverse 
bilayers with unique lipid compositions for applications such as phase separation 
studies. 
The His-tag and biotin-streptavidin methods also require modified proteins 
(i.e., His-tagged or biotinylated proteins) to compete for single substrates (e.g., 
nickel or streptavidin) on the membrane surface. If multiple modified-proteins 
were deposited on to a bilayer, they would compete for the same binding partners 
on the bilayer. Therefore, competitive binding on the membrane surface prohibits 
the production of biomimetic membranes with pre-determined concentrations for 
each type of modified protein. On the other hand, in the aldehyde tag method, 
because aldehyde-tagged proteins are reacted on small unilamellar vesicles 
(SUVs) containing aminooxy- lipids prior to SLB formation, multiple aldehyde-
tagged proteins my be reacted to different solutions of aminooxy- containing 
SUVs generating SUVs with the same lipid composition but varying aldehyde-
tagged proteins. Next these assorted SUVs may be combined (at specific volume 
ratios) through vesicle fusion, and deposit into a supported lipid bilayer. Table 1 
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below summarizes the advantages of the different protein attachment strategies 
that are currently used to attach proteins on biomimetic membranes: 
Table 1: A summary of the advantages and disadvantages of current membrane protein 
attachment strategies 
Protein 
Attachment 
Strategy 
 
C Terminus 
Modification 
 
N Terminus 
Modification 
Site-specific 
Modification 
Along the 
Protein 
Diversity in 
Lipid Anchor 
Motifs 
GPI  --- --- --- 
His Tag + 
Nickel 
  --- --- 
Biotin + 
Streptavidin 
  --- --- 
Aldehyde Tag     
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CONCLUSION AND FUTURE WORK 
 
Biological membranes not only provide a protective barrier for cells and 
their intracellular compartments, but also host all the machinery for cellular 
communication and transport across the bilayer that allows cellular function to 
proceed. Due to the high level of specificity in cellular signaling and trafficking, 
the correct arrangement and orientation of receptor proteins is integral to 
accurately managing chemical recognition. The aldehyde tag based method of 
covalent lipidation developed in this study permits protein modifications with an 
unrivaled freedom and accuracy that stretches beyond the biofunctionaliztion of 
biomimetic membranes. By varying the site of lipidation to include the aldehyde 
tag on the amino (N-) terminus or along the middle body of the EGFP, aldehyde 
tag expression at different areas of the EGFP, along with their effects on protein 
lipidation and membrane integration, will be explored in future work. In addition, 
by using a variety of anchoring lipid motifs, the dependence of the protein 
integration on the chemical structure of the lipid will be studied. By varying the 
chemical structure of the lipid anchors to reflect those with known phase 
separation (lipid arrangement) behavior, the ability of proteins (lipidated using the 
aldehyde-tag strategy) to partake in more complex membrane dynamics will be 
evaluated. Depending on the specific lipid motif, if the membrane system 
undergoes a phase transition induced by temperature change, the EGFP should 
redistribute in the membrane in expected patterns consistent with its lipid 
composition. Extending the aldehyde tag to lipidate antibodies would be a step 
towards defining sensory and drug delivery applications. Once the integration 
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technique is refined, different proteins may be aldehyde-tagged and lipidated for 
membrane integration and provide steps towards advancing biological, medical 
and biotechnological applications.  
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CAPSTONE SUMMARY 
 
 
A distinguishing feature of cellular life is the ability for animal cells to 
communicate, exchange, and process biochemical information. A variety of 
important chemical recognition events transpire on the cell membrane, which 
protects the cell’s inner environment. Proteins, such as antibodies and receptor 
proteins, attached to the membrane surface play a key role in the essential 
chemical recognition and information exchange within a cell or with the exterior 
environment outside the cell. Because of the high level of specificity in 
biochemical recognition, artificial membranes that interface with living cells must 
be developed in a way that allows proteins to freely reorganize themselves on the 
membrane surface. Therefore, efforts in maximizing the effectiveness of cell 
surface functionality in synthetic or artificial membrane systems is important in 
the advancement of biomedicine, biotechnology, and basic science.  
Human and animal cells contain a variety of lipid membrane-enclosed 
organelles – most importantly a nucleus that carries the organism’s genetic 
information. The entire exterior is protected by a cell membrane, composed of 
phospholipids, which are amphipathic molecules containing a hydrophilic (water-
loving) head region and two hydrophobic (water-fearing) fatty acid chains. In 
aqueous solution, the lipids form closed three-dimensional structure, called 
liposomes or vesicles, where all the hydrophilic heads facing out and the 
hydrophobic tails facing in. This configuration enforces a “like attracts like” 
phenomenon that keeps all the hydrophilic heads and hydrophobic tails facing 
their preferred environments. The wall of a liposome is therefore a continuous 
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bilayer where two leaflets of lipids situate on top of each other in the 
configuration mentioned above. At the surface, a cell is essentially a liposome 
with specialized organelles and membranes carrying out its life-sustaining 
processes. Therefore, many simplified model membrane systems or biomimetic 
membranes have been synthesized to study certain cell surface interactions and 
properties by mimicking sections or aspects of the cell membrane. 
Much like living cell membranes, biomimetic membrane systems often 
require specific proteins to be attached, via e.g., a lipid anchor on its surface, in 
order to carry out a specialized function. Lipids and proteins must be able to 
freely diffuse and rearrange across the surface of the bilayer. In many cases of 
cellular signaling, the coming together of multiple protein receptors is required for 
the proper signal to be created. However, current protein attachment strategies 
have been limited by both the site where a protein may be modified to attach to a 
lipid anchor and the types of commercially available lipids that may be coupled to 
a protein. For example, the histidine + nickel interaction has been exploited in the 
production of biomimetic lipid surfaces. A series of histidine amino acid residues 
are linked to either the C or N terminus (i.e., the two poles of a protein’s 
structure) and allowed to bind to nickel atoms attached on lipid anchors on a 
bilayer. However, since the His-tag may only be added to the two ends of a 
protein it does not permit proteins to be anchored to a lipid from its side or some 
location along the body of the protein. Furthermore, only one lipid anchor with a 
nickel atom on its head group is commercially available, thereby severely limiting 
the production of diverse membrane compositions. 
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With the recently developed aldehyde tag modification, a protein may be 
modified at virtually any location along its amino acid chain (the pre-protein 
structure) to bear a reactive aldehyde group that may bind to an aldehyde-specific 
binding partner including one of many modified lipid anchors. Lipid anchors 
modified to have an aminooxy- group may covalently bind with an aldehyde-
tagged protein for subsequent incorporation into a biomimetic bilayer. 
In this study, the aldehyde tag technology was incorporated into an 
enhanced fluorescence protein (EGFP) and later coupled to an aminooxy-
modified lipid anchor for deposition onto a supported lipid bilayer. A supported 
lipid bilayer is a biomimetic membrane system that allows the easy study of 
membrane surface assembly and structure with microscopy techniques. By using 
EGFP, which fluoresces green when exposed to the right, blue excitation light, the 
successful incorporation of the aldehyde-tagged EGFP lipid anchors will produce 
bilayers that can be imaged and examined for fluidity with a fluorescence 
microscope.  
A special six-amino-acid consensus sequence is first inserted into the C 
terminus EGFP’s amino acid chain. Next a formylglycine-generating enzyme 
(FGE) reads this sequence and converts the cysteine amino acid (that is in the 
sequence), into a formylglycine, which contains the aldehyde group. This 
consensus sequence offers the site-specific introduction of an aldehyde group, i.e., 
wherever the consensus sequence is inserted, the protein will be translated into its 
final structure with the aldehyde group at that location. Next commercially 
available phosphatidylethanolamine (PE) lipid anchors with varying fatty acid 
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chains may be aminooxy- modified and coupled with the tagged EGFP. This 
permits the freedom to generate assorted biomimetic membranes with unique lipid 
compositions for various biological studies and applications. In the experiment, 
aldehyde-tagged EGFPs were coupled/reacted on to small lipid vesicles 
containing aminooxy- lipids. The resulting solution of EGFP proteoliposomes 
were allowed to fuse, through a process called vesicle fusion, and flatten into a 
bilayer on glass substrate. 
Once a bilayer was formed, fluorescence recovery after photo-bleaching 
(FRAP) was used to analyze the mobility of the EGFP lipid anchors. In a FRAP 
study, a strong pulse of light is used to deactivate (“bleach”) the EGFP leaving a 
dark region of space, while over time, active EGFP attached to neighboring lipids 
will begin to diffuse into the region and effectively fill it with a darker shade of 
the original fluorescence color. FRAP studies of the bilayers revealed successful 
recovery supported the EGFP-lipid anchor integration. However, the presence of 
extra unbound or free non-aldehyde tagged EGFP, during the coupling reaction, 
may have interfered with the bilayer deposition process. These excess EGFP 
would permanently bind to the glass, bleach, and remain immobile, as 
neighboring lipids carrying functional EGFP must diffuse around them. This issue 
will be addressed with additional filtering to separate out the successfully reacted 
EGFP proteoliposomes before bilayer deposition. 
The successful FRAP analyses proved that the aldehyde tag may be used 
to couple proteins to lipid anchors while remaining functional and mobile when 
attached to a supported lipid bilayer. For the development of biomimetic 
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membranes, effectively any protein may be aldehyde tagged from any position to 
attach to a lipid anchor on a bilayer. In future work, by introducing the aldehyde 
tag at different sites along the EGFP, the effects of location on the successful 
aldehyde tag modification may be examined.  Furthermore, by tagging a different 
protein, such as an antibody, sensory applications may be further explored. 
Therefore, the aldehyde tag method provides a versatile and powerful way to 
modify proteins not only for attachment to lipid anchors but also for many other 
biological studies.  
 
 
